Stella

Gerber

Stella is a medical student at the University of Zürich. She wants to understand how pediatric cancers are being metabolically reprogrammed to sustain growth. She is currently studying MYCN amplified neuroblastoma cell lines using condition media and drug treatment. The objective of her project is to confirm MYCN dependency to specific amino acids, as it could be used for future therapy.